| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.1 - Asymptomatic | 2014 | Belgium | IgE | 15 | 6.670 | 20140718, Faber MA
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 17.900 | 20140625, Armentia A
| | 1.12 - Oral Allergy Syndrome | 2014 | Belgium | IgE | 38 | 2.630 | 20140718, Faber MA
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Belgium | IgE | 14 | 0.000 | 20140718, Faber MA
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 5.200 | 20140331, Rockmann H
| | 1.6 - Anaphylaxis, Diagnosed | 2014 | Belgium | IgE | 37 | 16.210 | 20140718, Faber MA
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
| | 10.1 - Normal Control | 2014 | Belgium | IgE | 15 | 0.000 | 20140718, Faber MA
| | 3.2.1 - Source Sensitized (IgE) | 2014 | United States | IgE | 29 | 20.700 | 20140606, Kattan JD
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2014 | Spain | IgE | 130 | 41.600 | 20140401, Armentia A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | United States | IgE | 13 | 46.200 | 20140606, Kattan JD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 5.710 | 20130605, Simon D
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 9.290 | 20130111, Ott H
| | 4.1.1 - Heterologous Source Sensitized (Symptoms) | 2013 | Netherlands | IgE | 82 | 3.660 | 20130415, Masthoff LJ
| | 5.1.1 - Source Exposed (Symptoms) | 2013 | Netherlands | IgE | 79 | 6.330 | 20130415, Masthoff LJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 3.1.1 - Source Sensitized (SPT) | 2012 | Spain | IgE | 79 | 73.420 | 20121016, Javaloyes G
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 36.400 | 20120726, Pedrosa M
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 16.200 | 20120726, Pedrosa M
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2012 | Netherlands | IgE | 42 | 11.900 | 20120905, Le TM
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 5.050 | 20110223, De Knop KJ
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Italy | IgE | 431 | 36.660 | 20111123, Bernardi ML
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 16.270 | 20101214, Gadisseur R
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Belgium | IgE | 20 | 0.000 | 20100628, Verweij MM
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Spain | IgE | 26 | 84.610 | 20100618, Hartz C
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 40.000 | 20091005, Ott H
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Italy | IgE | 26 | 50.000 | 20091204, Ciardiello MA
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 5.405 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Denmark | IgE | 21 | 0.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 38.090 | 20090808, Krause S
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 20 | 20.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 21 | 0.000 | 20090406, Skamstrup Hansen K
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Denmark | IgE | 20 | 5.000 | 20090406, Skamstrup Hansen K
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Spain | IgE | 17 | 71.000 | 20090406, Skamstrup Hansen K
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Switzerland | IgE | 20 | 15.000 | 20090406, Skamstrup Hansen K
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2004 | Spain | IgE (IB) | 26 | 61.500 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2004 | Germany / Switzerland | IgE (IB) | 65 | 0.000 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2003 | Denmark / Switzerland | IgE (IB) | 17 | 0.000 | |
|
Loading...
Cor a 8
